Silk Road Medical, Inc (NASDAQ:SILK) Q2 2023 Earnings Call Transcript August 1, 2023 Silk Road Medical, Inc beats earnings expectations. Reported EPS is $-0.35, expectations were $-0.39. Operator: Good afternoon and thank you for joining Silk Road Medical’s Second Quarter 2023 Earnings Call. [Operator Instructions] Now, I will turn the call over to Marissa Bych […]
InspireMD to Report Second Quarter 2023 Financial Results and Provide Corporate Business Update on Tuesday, August 8th tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Optimized medical therapy may be enough in patients with carotid artery stenosis who have a low to intermediate stroke risk, after the ESCT-2 trial showed no benefit from adding revascularization.